Logo

American Heart Association

Showing 0 Abstracts.

A Personal Risk Assessment Device in Patients with Chest Pain

Shvilkin Alexei , Zlatic Natasa , Atanasoski Vladimir , Grujovic Zdolsek Sanja , Popovic Maneski Lana , Miletic Marjan , Vukcevic Vladan

Presentation/Board Number: Mo4013

Scientific Sessions 2024

Novel Diagnostic Tools in ACS

161

A Perspective on Contributions of Lipoproteins to Atherogenesis and Atheroprotection

Chapman John

Presentation/Board Number:

Scientific Sessions 2024

Competing Roles of Lipids in Promotion and Prevention of Atherosclerosis

108

A pharmacist-led, population health approach to optimizing care in patients with hypertension and type II diabetes mellitus in minority groups

Doyle Julie , Haftel Elizabeth , Monroe Janet , Chen Zsu-zsu , Benson Mark , Yankama Tuyen , Adam Atif , Rubin Rochelle

Presentation/Board Number: MP1432

Scientific Sessions 2025

Optimizing CVD Outcomes in Diabetes: Risk Assessment and Innovative Therapeutic Strategies

34

A Pharmacist Medication Titration Program for Patients with Cardiac Sarcoidosis and Systolic Heart Failure

Sykora Daniel , Giudicessi John , Cooper Leslie , Rosenbaum Andrew , Olson Nicole , Churchill Robert , Kim Boyoung , Bratcher Melanie , Elwazir Mohamed , Young Kathleen , Abou-ezzeddine Omar , Bois John

Presentation/Board Number: Mo2174

Scientific Sessions 2024

From Hospital to Home: Implementation Science Across the HF Care Continuum

141

A pharmacovigilance investigation from the FAERS database on patients using pembrolizumab and its association with cardiac arrhythmias

Upreti Prakash , Jancic Predrag , Milutinovic Stefan , Rathore Azeem , Nassar Sameh , Karki Roshan , Rao Mohan , Patel Brijesh

Presentation/Board Number: Mo3035

Scientific Sessions 2024

Medications in Motion: Innovating Pharmacotherapy for Enhanced Treatment Outcomes

156

A Pharmacovigilance Study of Bempedoic Acid: Balancing Risks and Benefits

Khadka Sulochana , Timilsina Bibek , Matai Pallavi , Sharma Seema , Rajak Kripa , Calderon Barahona Gabriela , Oli Seema

Presentation/Board Number: Sa1029

Scientific Sessions 2024

Lipoproteins - Clinical and Translational Studies

144

A Phase 1, Single Ascending Dose Study to Evaluate ALN-TTRsc04, a Next-Generation RNA Interference Therapeutic, in Healthy Participants for Potential Treatment of Transthyretin Amyloidosis

Murad Ali , Lasko Maxwell , Badri Prajakta , Jadhav Satyawan , Boyle Katherine , Li Juanjuan , Vest John , Taubel Jorg

Presentation/Board Number: 4135443

Scientific Sessions 2024

Cutting Edge Clinical Cardiomyopathies Research

100

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Monthly or Quarterly Subcutaneous Administration of the Interleukin-6 Inhibitor Pacibekitug in Patients With Elevated High-Sensitivity C-Reactive Protein and Chronic Kidney Disease: 90-Day Analyses from TRANQUILITY

Pergola Pablo , Szarek Michael , Zayed Hany , Hemani Famina , Degoma Emil , Andorfer Cathy , Walsh John , Ridker Paul , Bhatt Deepak

Presentation/Board Number: MP1719

Scientific Sessions 2025

Top Clinical and Translational Abstracts in Vascular Medicine

28

A Phase 2 Study Evaluating the Effects of Mivelsiran, an Investigational RNA Interference Therapeutic, on Hemorrhagic and Nonhemorrhagic Manifestations of Cerebral Amyloid Angiopathy

Greenberg Steven , Parikh Neal , Lee Jin-moo , Van Etten Ellis , Van Osch Matthias , Klijn Catharina , Sostelly Alexandre , Goteti Sasikiran , Sepehrband Farshid , Avbersek Andreja , Deering Robert

Presentation/Board Number: OGCTP8

International Stroke Conference 2025

Ongoing Clinical Trials Posters

127

A Phase 2a randomized controlled trial of once-daily versus twice-daily remote ischemic conditioning in vascular cognitive impairment (TRIC-VCI)

Ganesh Aravind , Mccreary Cheryl , Sahlas Demetrios , Sharma Mukul , Swartz Richard , Smith Eric , Barber Philip , Black Sandra , Corbett Dale , Field Thalia , Frayne Richard , Hachinski Vladimir , Ismail Zahinoor , Mai Lauren

Presentation/Board Number: TP39

International Stroke Conference 2025

Brain Health Posters II

132

A Phase I, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of N-acetylgalactosamine Small Interfering RNA Conjugate, BPR-30221616, in Healthy Participants, for Potential Treatment of Transthyretin Amyloidosis

Han Xiaohong , Chen Rui , Cheng Xiwen , Zhang Langxi , Huang Haoxi , Fan Shengjun

Presentation/Board Number: MP973

Scientific Sessions 2025

Heart Failure and Cardiomyopathy: From Bench to Bedside

28

A phenomapping-informed machine learning tool estimates individualized cardiometabolic effects from Tirzepatide and generalizes to a new population.

Thangaraj Phyllis , Oikonomou Evangelos , Khera Rohan

Presentation/Board Number: MP2196

Scientific Sessions 2025

Next-Generation Risk Prediction: Leveraging Biomarkers and Omics for Precision Health

27